Abiraterone Acetate
Abiraterone acetate is indicated in combination with prednisone for the treatment of patients with. Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk…
Abiraterone acetate is indicated in combination with prednisone for the treatment of patients with. Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk…
YONSA is indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer. YONSA is a CYP17 inhibitor indicated in…
Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with. Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk…
Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with. Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk…
Bottle-label.
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2024. All Rights Reserved.